Logo Logo Logo Logo Logo
  • Home
  • About Us
    • Leadership Team
    • Board of Directors
    • Investors
  • Our Science
    • Our Science
    • Presentations & Publications
  • Our Portfolio
    • Our Platform
    • Our Pipeline
    • Our Lead Program – AMV564
  • Careers
    • Current Openings
  • News
  • Contact us
  • Home
  • About Us
    • Leadership Team
    • Board of Directors
    • Investors
  • Our Science
    • Our Science
    • Presentations & Publications
  • Our Portfolio
    • Our Platform
    • Our Pipeline
    • Our Lead Program – AMV564
  • Careers
    • Current Openings
  • News
  • Contact us

Presentations & Publications

2021 ASCO Presentation

2021 American Society of Cancer Research (AACR)

Selectivity of T Cell Engager AMV564 Against Different Leukemic Blast Populations and Potential Application for Patient Selection

2020 Society for Immunotherapy of Cancer (SITC) Annual Meeting Poster Presentation (Clinical Update)

2020 Society for Immunotherapy of Cancer (SITC) Annual Meeting Poster Presentation (Translational Data)

AACR Virtual Annual Meeting 2020 Recording

AACR Virtual Annual Meeting 2020 Presentation

ASCO Presentation 2020

ASH Oral Presentation 2019

SITC Oral Presentation 2019

SITC Poster Presentation 2019

EHA Oral Presentation 2019

ASH Poster Presentation 2018

EHA Oral Presentation 2018

ASH Oral Presentation 2017

Amphivena Therapeutics Two Tower Place Suite 1000
South San Francisco, CA 94080


650-499-3178
HOME

ABOUT US
Leadership
Board of Directors
Investors
OUR SCIENCE
Presentations & Publications

OUR PORTFOLIO
Our Platform
Our Pipeline
Our Lead Program
CAREERS
Current Openings

LATEST NEWS

CONTACT US

CONNECT
©Copyright 2021 Amphivena Therapeutics. All Rights Reserved.   Privacy Policy   Terms of Use